Massive Bio Launches TrialRelay™ at SCOPE 2026: An Operating System to End “Referral Black Holes” in Oncologynews2026-02-02T15:38:49+00:00February 2nd, 2026|Medical Device News Magazine|
Europe VAM February contract talks begin as LyondellBasell declares FM in Americasnews2026-02-02T15:38:00+00:00February 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
FOCUS: Europe MMA prices firming as arbitrage closes and imports limitednews2026-02-02T15:36:00+00:00February 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
Diffuse Bio Announces Push-Button Platform for Ultra-Fast Biologics Discovery at Scalenews2026-02-02T15:33:04+00:00February 2nd, 2026|Medical Device News Magazine|
Texas Cardiac Arrhythmia Institute First in U.S. to Implant FDA-Approved Novel Defibrillation Leadnews2026-02-02T15:27:06+00:00February 2nd, 2026|Medical Device News Magazine|
CORRECTION: Greek consortium signs agreement to supply US LNG to Ukraine in Marchnews2026-02-02T15:25:00+00:00February 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
Kyowa Kirin reveals side effect in trial; GSK was lone bidder for RAPTnews2026-02-02T15:22:27+00:00February 2nd, 2026|Endpoints News|
Medtronic Diabetes expands access to comprehensive insulin delivery solutions following Medicare coverage and new FDA clearancesnews2026-02-02T15:19:19+00:00February 2nd, 2026|Medical Device News Magazine|
FDA rejects Aquestive’s allergy drug over packaging issuesnews2026-02-02T15:17:06+00:00February 2nd, 2026|Endpoints News|
Europe CX February contract firms with feedstocknews2026-02-02T14:52:00+00:00February 2nd, 2026|Independent Commodity Intelligence Services (ICIS)|
